Abrdn PLC Merck & Co., Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abrdn PLC holds 4,526,331 shares of MRK stock, worth $383 Million. This represents 0.62% of its overall portfolio holdings.
Number of Shares
4,526,331
Previous 4,513,993
0.27%
Holding current value
$383 Million
Previous $405 Million
11.57%
% of portfolio
0.62%
Previous 0.8%
Shares
35 transactions
Others Institutions Holding MRK
# of Institutions
3,888Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$21.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.2 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.92 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$5.05 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $215B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...